DarioHealth Corp. has announced it has surpassed 100 scientific studies, including peer-reviewed journal publications and peer-reviewed conference abstracts, reinforcing its leadership in evidence-based digital health. The company highlighted that these results have already been presented in respected venues such as the Journal of Medical Internet Research and major conferences. DarioHealth’s research portfolio includes large, real-world study populations, longitudinal designs of up to two years, independent third-party validations, and directly observed outcomes like claims reduction and improved HbA1c levels. This milestone places DarioHealth among the top digital health vendors for scientific rigor and measurable impact, distinguishing it as a trusted partner for employers and health plans seeking validated solutions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DarioHealth Corp. published the original content used to generate this news brief via PR Newswire (Ref. ID: LN67305) on January 21, 2026, and is solely responsible for the information contained therein.